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Background: Modification of endosteal implants through surface treatments have been investigated to improve os-
seointegration. Boronization has demonstrated favorable mechanical properties, but limited studies have assessed 
translational, in vivo outcomes. This study investigated the effect of implant surface boronization on bone healing.
Material and Methods: Two implant surface roughness profiles (acid etched, machined) in CP titanium (type 
II) alloy implants were boronized by solid-state diffusion until 10-15µm boron coating was achieved. The sur-
face-treated implants were placed bilaterally into 5 adult sheep ilia for three and six weeks. Four implant groups 
were tested: boronized machined (BM), boronized acid-etched (BAA), control machined (CM), and control ac-
id-etched (CAA). Osseointegration was quantified by calculating bone to implant contact (BIC) and bone area 
fraction occupancy (BAFO).
Results: Both implant types treated with boronization had BIC values not statistically different from machined 
control implants at t=3 weeks, and significantly less than acid-etched control (p<0.02). BAFO values were not 
statistically different for all 3-week groups except machined control (significantly less at p <0.02). BAFO had a 
significant downward trend from 3 to 6 weeks in both boronized implant types (p<0.03) while both control im-
plant types had significant increases in BIC and BAFO from 3 to 6 weeks.
Conclusions: Non-decalcified histology depicted intramembranous-like healing/remodeling in bone for controls, 
but an absence of this dynamic process in bone for boronized implants. These findings are inconsistent with in 
vitro work describing bone regenerative properties of elemental Boron and suggests that effects of boron on in vivo 
bone healing warrant further investigation.
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The translational applications of boronized titanium 
implants and bone healing have not been extensively 
explored in vivo, but in vitro studies have shown a fa-
vorable cell growth rate, with excellent blood compat-
ibility with low hemolysis level (<0.12%) on plasma sin-
tered composite TiB2-Ti within a 48-hour duration when 
compared with CP Ti (0.17%) and Ti-6Al-4V (0.36%). In 
vivo investigations testing the effect of boron incorpora-
tion to PLGA scaffolds for hard tissue healing proved 
promising as bone mineralization density and computed 
tomography analysis proved that scaffolds with boron 
increased healing rates of bone defects in a rat femur 
(9). Boron significantly increased levels of mineraliza-
tion and bone associated protein expression in osteo-
blast formation, bone densification, mineral content, 
and mechanical properties. In vivo work has described 
beneficial effects of dietary boron on bone strength in 
rabbit models (10). Despite these promising systemic 
effects, the effects of boron on healing through local-
ized biomaterial delivery have not been investigated in 
larger models to date.
The present study explored the effect of boriding on 
the early osseointegration of titanium implants in a 
highly translational large animal model. The hypoth-
eses of the study were (i) that boron containing sur-
faces will present similar osseointegration degrees to 
titanium surfaces, and that (ii) acid etched surfaces 
will present higher osseointegration degrees relative to 




Prior to boronization treatment, the Type II CP titanium 
implants (4mm diameter and 10mm length) in this study 
were first cleaned with acetone in an ultrasound bath, 
dried with compressed air, and then chemically etched 
for thirty seconds with a solution mixture of Nitric acid 
and Hydrofluoric acid mixed in a 10:1 ratio. Afterwards, 
the implants were washed in distilled water, soaked in 
acetone, and left to air dry.
Titanium implant boronization was performed by solid 
state diffusion using a powder mixture of 97% weight 
amorphous boron (SB Boron 90, SB Boron Corpora-
tion), 2% weight boron carbide (240 grit, technical 
grade, Electro Abrasive Corp.), and 1% weight potas-
sium fluoroborate (KBF4) (Alfa Aesar) as an activator. 
The boron powder mixture was dried in a box furnace 
(ThermoLyne, model 48015) at 250°C for two hours. 
After the heating process was completed, the mixture 
was removed from heat to permit cooling.
A ceramic process crucible was filled halfway with 
the dried powder mixture; the titanium coupons were 
placed in the crucible approximately 1 cm apart, and 
fully submerged by approximately 10 mm from in the 
Introduction
Successful endosteal implant placement is measured 
by a desired bone healing response that results in pre-
dictable long-term implant stability and function. This 
necessary response, termed osseointegration, is gov-
erned by the tissue-implant surface interface, implant 
geometry, surgical procedure/placement and the bone 
remodeling processes over time (1). Bone remodeling, 
initiated post-surgically and affected by primary and 
secondary stability, leads to the adaptation and healing 
of bone at the interface of the implant.  The biological 
interface, composed of cellular and extracellular struc-
tures, is directly exposed to the surface chemistry of the 
implant (2). The successful application of these princi-
ples has resulted in over 2.2 million pounds of titanium 
devices implanted into patients worldwide every year. 
However, implant fatigue continues to be an important 
cause of implant failure, with reports in the dental and 
orthopaedic literature alike (3,4), citing the need for 
manufacturing procedures that can strengthen and im-
prove osseointegration and wear resistance.
Numerous studies have focused on techniques to im-
prove osseointegration and wear, such as implant sur-
face treatments. Surface modification can significantly 
alter its physico-chemical properties without altering 
desired bulk properties (5). This addresses the need for 
superior integration between bone and implant while re-
taining desired bulk characteristics of an implant mate-
rial. Chemical and/or physical surface treatments such 
as hydroxyapatite coating, acid etching, and sandblast-
ing have all shown various degrees of increased initial 
stability in vivo when applied to metallic implants (6). 
In living systems, where implant-bone remodeling has 
been shown to continue up to 5 years when stimulated 
by masticatory loading, the ability of energy absorption 
is an important factor in the long-term success of the 
implant (7). It is therefore important to improve the tri-
bological, wear properties, and surface treatment meth-
ods of implants, in both dental and orthopaedic markets. 
Methods including laser, plasma surface treatments, ion 
nitriding and solid-state diffusion have all been investi-
gated to achieve these goals.
Boronization, or boriding, is a thermo-chemical treat-
ment in which boron atoms diffuse into metals resulting 
in a nanocrystalline hardening surface layer  (8). The 
boron atoms are limited to the nanocrystalline layer and 
form a range of hard metal boride phases, which has 
been shown to contribute high wear resistance, corro-
sion resistance, and up to a ten time increase in service 
life of implants. Conventional processes available for 
boronizing vary but the most widely used is pack bo-
ronizing, which uses solid precursors in powder form to 
undergo solid-state diffusion. This process is inexpen-
sive and simple/flexible in deployment, thereby allowing 
for the coating of complex geometric bulk constructs.
e3
Assessing osseointegration of boronized metallic implants Med Oral Patol Oral Cir Bucal-AHEAD OF PRINT - ARTICLE IN PRESS
ceramic crucible. The remaining dried powder mixture 
was then placed on top of the titanium coupons to fill 
the crucible. Upon complete filling of the crucible, the 
crucible was shaken to make sure the powder complete-
ly surrounded the coupons and any residual voids in the 
powder solution.
The filled crucible was then placed into a vacuum fur-
nace (CM Furnaces Corp.,) at 250°C for four hours. 
Next, the temperature was increased to 1100°C and the 
diffusion process was carried over 8 hours in an argon 
technical grade atmosphere with the flow of argon 5 
m3/h. After eight hours, the furnace was cooled down to 
250°C while still under an argon atmosphere, and then 
the furnace was turned off. After the furnace cooled 
down to room temperature, the boronized implants 
were removed from the powder mixture and cleaned 
with methanol in an ultrasound tank.
In order to measure the thickness of the boron coat 
achieved, cross sections were made, samples were 
etched, and a Zeiss Optical Microscope was used to 
measure the coat. The thickness of the boron coating 
was 10-15µm. After the treatment process and prior 
to any implantation were subjected to sterilization by 
gamma irradiation (CellRad Faxitron Tucson, AZ) at a 
dose of 25 kGY.
- Surgical Approach
An ovine hip model was used due to the low-density 
bone configuration and size, which allowed for place-
ment of all experimental groups within each subject 
minimizing the number of animals used. The study 
was conducted in accordance with ethical guidelines 
from the Institutional Animal Care and Use Commit-
tee under ARRIVE guidelines (Comité d’éthique An-
ses/ENVA/UPEC Approval Reference#: 13-011). Fol-
lowing the approval from the committee a total of five 
male sheep (each weighing ~55kg) were acquired and 
allowed to acclimate for 7-days at the facility. After the 
acclimatization period the sheep were subjected to the 
previously approved protocol for the surgical proce-
dures for the sheep ilia. Due to the size of the iliac crest 
in the species, experimental groups were nested within 
subject, allowing for an increase in statistical power and 
decrease in the number of animals.  Four implants were 
inserted in sheep ilia bilaterally yielding to 40 implants 
total (n=20/per time in vivo) (20 implants with surface 
treatments and 20 control). Two time points were ana-
lyzed in this study, the first surgical procedure was per-
formed on the left hip, which provided the 6-week time 
point, and subsequently 3-weeks after the initial surgi-
cal procedures the right hip was operated in order to 
provide the 3-week in vivo time point. The study com-
prised of four different groups of implants to be ana-
lyzed in this experiment: boronized machined (BM), 
boronized acid-etched (BAA), control machined (CM), 
and control acid-etched (CAA).
Prior to surgery, anesthesia was induced with sodium 
pentothal (15-20 mg/kg) in Normasol solution into the 
jugular vein and maintained with isofluorane (1.5-3%) 
in O2/N2O (50/50). Animal monitoring included ECG, 
end tidal CO2, and SpO2 and body temperature, which 
was regulated by a circulating hot water blanket. Prior to 
surgery, the surgical site was shaved and iodine solution 
was applied to prepare surgical site. A ~10 cm incision 
was made along the iliac crest, adipose and muscular 
tissue dissected, exposing the ilium (11). Drilling was 
performed at 1100 rpm under saline irrigation. The final 
diameter of drills utilized was 3.8 mm. Individual im-
plant group position within the ilia were interpolated as 
a function of animal subject to minimize location bias. 
Layered closure was performed. Cefazolin (500 mg) was 
administered intravenously pre-operatively and post-
operatively. Post-operatively, sheep were transported to 
their stall for recovery, with food and water provided ad 
libitum. At the designated time point the animals were 
euthanized by anesthesia overdose, which included the 
administration of a combination of Telazol (2–5 mg/kg; 
intramuscular) and Xylazine (2 mg/kg; intramuscular), 
followed by the placement of an intravenous catheter in 
the ear, used to administer 120 mg/kg, intravenously, 
of sodium pentobarbital. Death was confirmed by aus-
cultation, absence of heartbeat, and EKG. The samples 
were retrieved en bloc and placed in formalin solution 
for 24 hours followed by ethanol solution until histo-
logical processing.
- Histological Preparation and Histomorphometry 
Each experimental group was processed for histologic 
evaluation via progressive dehydration and infiltra-
tion using ethanol and methyl salicylate, respectively, 
followed by final embedding in methyl methacrylate 
(MMA) as previously reported. The blocks were then 
cross-sectioned along the long axis of each implant with 
a slow-speed diamond saw (Isomet 2000, Buehler Ltd., 
Lake Bluff, IL, USA) to create slices as thin as 100 
micrometers(μm). These histologic cuts were glued to 
an acrylic slide with acrylate-based adhesive (Loctite 
prism 408 industrial adhesive) and subsequently grind-
ed and polished, with water irrigation, using progres-
sively finer silicon carbide (SiC) abrasive papers (600, 
800, and 1200) (Metaserv 3000, Buehler Ltd., Lake 
Bluff, IL, USA) to achieve a final thickness of ~75 μm. 
Final sections were stained with Stevenel’s Blue and 
Van Gieson’s Picro Fuschin (SVG) stains. Histologi-
cal observations and images were digitalized using an 
automated Aperio slide scanning system and accompa-
nying computer software (Aperio Technologies, Vista, 
CA, USA). Osseointegration and bone growth was 
quantified and evaluated using a specific image analysis 
software (ImageJ, NIH, Bethesda, MD). A single user 
blinded to the implant groups and distribution, quanti-
fied bone-implant contact (BIC) and bone area fraction 
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occupancy (BAFO) to determine osseointegration level 
of implants. BIC quantifies the degree of osseointegra-
tion by calculating the percentage of bone in contact 
with the implant’s perimeter, while BAFO quantifies 
bone within the implant thread.
- Statistical Analysis
All histomorphometric and biomechanical testing data 
are presented as mean values with the correspond-
ing 95% confidence interval values (mean ± 95% CI). 
%BIC and %BAFO data were analyzed using a linear 
mixed model with fixed factors of implant surface tex-
ture (AA and M), boronization (B) presence or absence, 
control (C) and time point (3 and 6 weeks).  All analysis 
was completed with IBM SPSS (v23, IBM Corp., Ar-
monk, NY).
Results
Qualitative surface characterization was accomplished 
using scanning electron microscopy (SEM) (Hitachi 
S3500N) and was performed at various magnifications 
under an acceleration voltage of 5kV to observe the sur-
face topography of each group (n = 1 per surface) (Fig. 
1.  As seen in the SEM micrographs, the control acid-
etched (CAA) (Fig. 1) illustrated a surface with a more 
pronounced topography in comparison to the smooth 
surface of the control machined (CM) implant with its 
machined grooves (Fig. 1).
No evident signs of inflammation or infection were 
observed during immediate and longer-term post-op-
erative routines. After necropsy, clinical stability was 
detected for all implants.
The histomorphometric results demonstrated no sig-
nificant differences for bone to implant contact (BIC) 
and bone area fraction occupancy (BAFO) values for 
boronized implant groups as a function of surface 
texture (as machined (M) vs acid etched (AA)) at the 
individual time points, 3- and 6-weeks (p>0.05) (Fig. 
2). At 3 weeks, only a significantly higher BIC value 
was observed for the CAA group (p<0.02) while the 
BAA, BM and CM values showed no significant differ-
ences (Fig. 2). On the other hand, when evaluating as a 
function of time (3- vs 6-weeks) significantly (p<0.01) 
higher values of BIC were observed for the BAA group 
between at the earlier time point (3-weeks), 21.73%±7.9 
vs 5.93%±9.7 (6-weeks), while no statistical differences 
were observed for BM samples between the time points 
(16.44%±7.9 (3 weeks) vs 8.9%±9.7 (6 weeks)) (Fig. 2). 
When evaluating for all factors (time, surface texture, 
and presence or absence of boron on the surface) mean 
BIC values for the BM implants showed no significant 
differences, between 3 and 6-weeks, while BAA result-
ed in significant decrease from 3- to 6-weeks (Fig. 2).
Subsequently, when evaluating for BAFO of the re-
spective implant groups, significantly (p<0.02) higher 
values were observed for BAA (25.82%±6.6), BM 
(27.29%±6.6) and CAA (30.76%±6.6) vs the CM 
(19.92%±6.6) group at 3 weeks (Fig. 2).  When evaluat-
ing BAFO as a function of time in vivo (3- vs 6-weeks), 
a significant (p<0.03) decrease for BAFO was observed 
for both the BAA and BM groups (Fig. 2), while a sig-
nificant increase was detected for both CAA and CM 
groups (Fig. 2).
Fig. 1: Scanning electron micrograph of: (A) machined titanium implant surface indicating the commonly seen grooved 
appearance (control machined, (CM)), (B) boronized machined (BM), (C) acid etched titanium implant surface show-
ing the distribution of small peaks and divots (control acid-etched (CAA)), and (D) boronized acid-etched (BAA).
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Histological observation at various magnifications sup-
ported the histomorphometric BIC and BAFO statisti-
cal findings.  While new bone growth was observed in 
proximity and in contact with all groups investigated at 
3 weeks (Fig. 3), the amount of bone contact and frac-
tion occupancy between threads decreased for the boron 
diffused surfaces (Fig. 3). The amount of bone observed 
in contact for the control implants increased over time. 
From a morphological perspective, normal progressive 
remodeling of bone is observed for the control groups 
(Fig. 3), such dynamic change were not observed for the 
boron containing groups over time (Fig. 3).
Fig. 2: BIC (a) and BAFO (b) as a function of time points (three vs. six weeks) and surface treatment (acid etched vs. machined) within each group 
(boronization vs. control). Letters indicate statistically homogenous groups.
Fig. 3: Optical micrographs taken at 3- and 6-week time point at healing chamber and bone interface. (A) Control-
machined implant group. 3-weeks: (B) Boron-machined implant group. (C) Control acid-etched implant group. (D) 
Boron acid-etched implant group. 6-week: (E) Control-machined implant group, (F) Boron-machined implant group, 
(G) Control acid-etched implant group, and (H) Boron acid-etched implant group.
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Discussion
The effects of boronization on metallic material proper-
ties are both well-documented and favorable. The aim 
of this study was to elucidate the effect of boronization 
on osseointegration. Boriding implant surfaces prior to 
surgery affected the osseointegration of the implants for 
at least six weeks in vivo, as supported by decreased 
BIC and BAFO when compared to control groups, as 
well as diminished overall osseointegration, and demin-
eralization.
Surface treatment with boron produces a TiB phase 
on titanium substrates that can improve the surface 
hardness, mechanical properties, corrosion resistance 
as well as good cytocompatibility. Similar to nitrid-
ing and carburizing, boronizing is a thermo-chemical 
heat treatment used to improve the wear and corrosion 
resistance over decades of use. Indeed, boride coating 
has actually been shown provide greater surface hard-
ness and higher wear resistance than nitride and carbide 
coatings. However, while findings are well-established 
in materials science investigations, translational appli-
cations have been more limited. In the present transla-
tional study, the application of these material science 
properties into a biological system resulted in unfavor-
able healing for up to six weeks in vivo, suggesting that 
factors that have previously not been considered when 
attempting to boride merit investigation, such as ideal 
concentration, and the effect of boron on indirect me-
diators of bone healing, such as osteoclast/osteoblast 
precursors and macrophages.
The limited number of small animal model studies in-
vestigating the role of boron for bone repair have showed 
that boron has osteogenic potential. Chen et al. used bo-
ron-coated mesoporous bioactive glass to improve the 
bone regenerative capacity and mechanical properties 
of bone derived from a novel nanogel (12). Gorustovic et 
al. implanted boron-modified bioactive glass particles 
in rat tibia bone marrow and determined that greater 
degrees of bone with higher calcium to phosphorus 
ratios formed consequent to boron (13). Other studies 
have demonstrated that tissue-engineered polymeric 
scaffolds infused with boron significantly increase 
osteoblast activity in rabbit calvaria, thereby warrant-
ing the investigation of these principles in larger, more 
translational animal models in this study. Although the 
treatment of devices with boron in low doses for bone 
tissue engineering has been previously demonstrated by 
Hakki et al., there currently exists no evidence that the 
incorporation of boron has exerted cellular or systemic 
toxicity.
Implants subjected to boronization unexpectedly de-
clined in bone formation at the implant surface over 
time. At six weeks in vivo, there was significantly less 
bone growth within the implant healing chambers mea-
sured by BAFO analysis and observed histologically. 
Acid-etched implants subjected to boriding also exhib-
ited this same trend to an even greater degree. This is 
likely attributed to the fact that acid-etching increases 
surface area of the implant, thereby subjecting bone 
to an even greater degree to boron diffusion. Of note, 
demineralized regions of woven bone growth were no-
ticed in the BAE group focally within bone remodel-
ing regions and not mature lamellar bone. This suggests 
that the effects observed may be linked to early stages 
of bone remodeling. These unexpected outcomes are 
inconsistent with previous reports highlighting the im-
portant role of boron in bone homeostasis (14) and war-
rant future investigation of ideal and supra-physiologic 
boron diffusing from the TiB2/TiB micron deep implant 
surface at local bone sites, as well as the potentially 
toxic effects on bone formation.
The study was effective in determining the effect that 
boronizing metal implants with various surfaces have 
on new bone growth and osseointegration post-surgi-
cally. The initial hypothesis of increased integration 
was disproven at later time points, as the boronization 
decreased new bone growth and even demineralized 
pockets of woven bone back to the osteoid state. This re-
sult could potentially be applicable in numerous patho-
logic states of bone overgrowth. Also, further boroniza-
tion studies are needed to assess the ideal processing 
parameters that would allow for increased bone growth 
and tribological surface properties without negative ef-
fects on bone remodeling.
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